News


Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614

By JLABS

Read full story
Other news

Distributed Bio announces a deal to identify pre-optimized antibodies using their SuperHuman antibody library platform

By JLABS

Read full story
Other news

Arcturus Therapeutics expands collaboration with Takeda Pharmaceuticals

By JLABS

Read full story
Other news

Kara Bortone, Ph.D., Head of Johnson & JohnsonInnovation, JLABS in San Diego shares why her role is the coolest job in San Diego in San Diego Magazine

By JLABS

Read full story
Other news

Alumni, Batu Biologics, has secured $1.3M in crowdfunding to develop its clinical stage tumor-angiogenesis targeting immunotherapy, ValloVax

By JLABS

Read full story
Other news

Distributed Bio announces platform transfer - Super Human library of 76 billion antibodies enables partners to search specific therapeutic antibodies @ unprecedented speeds

By JLABS

Read full story
Other news

AmarantusBio announces positivedata for MANF

By JLABS

Read full story
Other news

StemoniX has received a Most Innovative New Product Award for their microHeart® technology in the Diagnostics and Research Tools category

By JLABS

Read full story
Other news

Pionyr Immunotherapeutics completes Series B of $62M led by @NEA.

By JLABS

Read full story
Other news

Alector and AbbVie Announce Collaboration to Advance a Novel Class of Immune Therapies for Patients with Alzheimer's Disease

By JLABS

Read full story